Vanessa Drendel
Hugstetter Str. 55
Freiburg, BW 79106, Germany
Freiburg, BW 79106, Germany
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 31 publications
Author Correction: Breast cancer plasticity is restricted by a LATS1-NCOR1 repressive axis.
Journal: Nature communications
Published: January 10, 2023
Breast cancer plasticity is restricted by a LATS1-NCOR1 repressive axis.
Journal: Nature communications
Published: January 12, 2022
Voxel-based comparison of [68Ga]Ga-RM2-PET/CT and [68Ga]Ga-PSMA-11-PET/CT with histopathology for diagnosis of primary prostate cancer.
Journal: EJNMMI research
Published: April 14, 2020
Results from extended lymphadenectomies with [111In]PSMA-617 for intraoperative detection of PSMA-PET/CT-positive nodal metastatic prostate cancer.
Journal: EJNMMI research
Published: November 30, 2019
Detection Rate of 18F-Choline PET/CT and 68Ga-PSMA-HBED-CC PET/CT for Prostate Cancer Lymph Node Metastases with Direct Link from PET to Histopathology: Dependence on the Size of Tumor Deposits in Lymph Nodes.
Journal: Journal of nuclear medicine : official publication, Society of Nuclear Medicine
Published: January 27, 2019
Accuracy of [68Ga]Ga-RM2-PET/CT for diagnosis of primary prostate cancer compared to histopathology.
Accuracy of [68Ga]Ga-RM2-PET/CT for diagnosis of primary prostate cancer compared to histopathology.
Journal: Nuclear medicine and biology
Published: December 09, 2018
Proteomic distinction of renal oncocytomas and chromophobe renal cell carcinomas.
Journal: Clinical proteomics
Published: April 16, 2018
Focal dose escalation for prostate cancer using 68Ga-HBED-CC PSMA PET/CT and MRI: a planning study based on histology reference.
Journal: Radiation oncology (London, England)
Published: March 07, 2018
Performance of 111In-labelled PSMA ligand in patients with nodal metastatic prostate cancer: correlation between tracer uptake and histopathology from lymphadenectomy.
Journal: European journal of nuclear medicine and molecular imaging
Published: March 04, 2018
Proteomic Characterization of Prostate Cancer to Distinguish Nonmetastasizing and Metastasizing Primary Tumors and Lymph Node Metastases.
Journal: Neoplasia (New York, N.Y.)
Published: June 09, 2017
Last Updated: 09/26/2026